187 related articles for article (PubMed ID: 31951758)
1. Hepatitis B-related glomerulonephritis and optimization of treatment.
Liu Y; Shi C; Fan J; Wang B; Li G
Expert Rev Gastroenterol Hepatol; 2020 Feb; 14(2):113-125. PubMed ID: 31951758
[No Abstract] [Full Text] [Related]
2. Meta-analysis of the efficacy and safety of nucleotide/nucleoside analog monotherapy for hepatitis B virus-associated glomerulonephritis.
Wang WN; Wu MY; Ma FZ; Sun T; Xu ZG
Clin Nephrol; 2016 Jan; 85(1):21-9. PubMed ID: 26636326
[TBL] [Abstract][Full Text] [Related]
3. Meta-analysis of combined therapy for adult hepatitis B virus-associated glomerulonephritis.
Zheng XY; Wei RB; Tang L; Li P; Zheng XD
World J Gastroenterol; 2012 Feb; 18(8):821-32. PubMed ID: 22371643
[TBL] [Abstract][Full Text] [Related]
4. Toward a Cure for Hepatitis B Virus Infection: Combination Therapy Involving Viral Suppression and Immune Modulation and Long-term Outcome.
Wu D; Ning Q
J Infect Dis; 2017 Nov; 216(suppl_8):S771-S777. PubMed ID: 29156046
[TBL] [Abstract][Full Text] [Related]
5. Hepatitis B virus-associated glomerulonephritis in HBsAg serological-negative patients.
Li D; Gao G; Jiang H; Tang Z; Yu Y; Zang G
Eur J Gastroenterol Hepatol; 2015 Jan; 27(1):65-9. PubMed ID: 25386761
[TBL] [Abstract][Full Text] [Related]
6. Why do I treat HBeAg-negative chronic hepatitis B patients with nucleos(t)ide analogues?
Papatheodoridis GV
Liver Int; 2013 Feb; 33 Suppl 1():151-6. PubMed ID: 23286859
[TBL] [Abstract][Full Text] [Related]
7. Clinical and pathological characteristics of 5 children with HBV surface antigen (HBsAg)-negative hepatitis B virus-associated glomerulonephritis.
Liu T; Yang S; Yue Z; Kuang Y; Guan W; Sun L
J Clin Virol; 2015 May; 66():1-5. PubMed ID: 25866326
[TBL] [Abstract][Full Text] [Related]
8. Treatment of chronic hepatitis B: case selection and duration of therapy.
Leung N
J Gastroenterol Hepatol; 2002 Apr; 17(4):409-14. PubMed ID: 11982721
[TBL] [Abstract][Full Text] [Related]
9. Treatment of HBeAg positive chronic hepatitis B: interferon or nucleoside analogues.
Dusheiko G
Liver Int; 2013 Feb; 33 Suppl 1():137-50. PubMed ID: 23286858
[TBL] [Abstract][Full Text] [Related]
10. Latest developments in the treatment of hepatitis B.
Dandri M; Petersen J
Minerva Gastroenterol Dietol; 2016 Mar; 62(1):88-102. PubMed ID: 26448309
[TBL] [Abstract][Full Text] [Related]
11. Seroconversion of hepatitis B envelope antigen by entecavir in a child with hepatitis B virus-related membranous nephropathy.
Igarashi T; Shimizu A; Igarashi T; Hanaoka K; Yoshizaki K; Shigemori T; Shimizu S; Komeichi H; Itoh Y
J Nippon Med Sch; 2013; 80(5):387-95. PubMed ID: 24189358
[TBL] [Abstract][Full Text] [Related]
12. Nucleoside/nucleotide analogues in the treatment of chronic hepatitis B.
Fung J; Lai CL; Seto WK; Yuen MF
J Antimicrob Chemother; 2011 Dec; 66(12):2715-25. PubMed ID: 21965435
[TBL] [Abstract][Full Text] [Related]
13. HBeAg-positive chronic hepatitis B: why do I treat my patients with pegylated interferon?
Kao JH
Liver Int; 2014 Feb; 34 Suppl 1():112-9. PubMed ID: 24373087
[TBL] [Abstract][Full Text] [Related]
14. Glomerular Diseases Associated With Hepatitis B and C.
Gupta A; Quigg RJ
Adv Chronic Kidney Dis; 2015 Sep; 22(5):343-51. PubMed ID: 26311595
[TBL] [Abstract][Full Text] [Related]
15. Current developments in nucleoside/nucleotide analogues for hepatitis B.
Lo AO; Wong GL
Expert Rev Gastroenterol Hepatol; 2014 Aug; 8(6):607-22. PubMed ID: 24787673
[TBL] [Abstract][Full Text] [Related]
16. Treatment of hepatitis B virus associated glomerulonephritis with recombinant human alpha interferon.
Chung DR; Yang WS; Kim SB; Yu E; Chung YH; Lee Y; Park JS
Am J Nephrol; 1997; 17(2):112-7. PubMed ID: 9096440
[TBL] [Abstract][Full Text] [Related]
17. Viral-Associated GN: Hepatitis B and Other Viral Infections.
Kupin WL
Clin J Am Soc Nephrol; 2017 Sep; 12(9):1529-1533. PubMed ID: 27797900
[TBL] [Abstract][Full Text] [Related]
18. Antiviral treatment for chronic hepatitis B virus infection--immune modulation or viral suppression?
Buster EH; Janssen HL
Neth J Med; 2006 Jun; 64(6):175-85. PubMed ID: 16788215
[TBL] [Abstract][Full Text] [Related]
19. A 24-week, parallel-group, open-label, randomized clinical trial comparing the early antiviral efficacy of telbivudine and entecavir in the treatment of hepatitis B e antigen-positive chronic hepatitis B virus infection in adult Chinese patients.
Zheng MH; Shi KQ; Dai ZJ; Ye C; Chen YP
Clin Ther; 2010 Apr; 32(4):649-58. PubMed ID: 20435234
[TBL] [Abstract][Full Text] [Related]
20. HBeAg-positive chronic hepatitis B: why do i treat my patients with Nucleos(t)ide analogs?
Buti M
Liver Int; 2014 Feb; 34 Suppl 1():108-11. PubMed ID: 24373086
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]